Highlights and Quick Summary
- Income after Tax for the quarter ending December 31, 2022 was $-26.8 Million (a 250.9% increase compared to previous quarter)
- Year-over-year quarterly Income after Tax increased by 39.33%
- Annual Income after Tax for 2022 was $-79.8 Million (a -28.0% decrease from previous year)
- Annual Income after Tax for 2021 was $-111 Million (a 6.09% increase from previous year)
- Annual Income after Tax for 2020 was $-104 Million (a -38.68% decrease from previous year)
- Twelve month Income after Tax ending December 31, 2022 was $-79.8 Million (a -5.77% decrease compared to previous quarter)
- Twelve month trailing Income after Tax decreased by -26.28% year-over-year
Trailing Income after Tax for the last four month:
31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
---|---|---|---|
$-79.8 Million | $-84.7 Million | $-103 Million | $-108 Million |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Income after Tax of Precigen, Inc.
Most recent Income after Taxof PGEN including historical data for past 10 years.Interactive Chart of Income after Tax of Precigen, Inc.
Precigen, Inc. Income after Tax for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | $-26.82 | $-7.64 | $-26.06 | $-19.25 | $-79.78 |
2021 | $-31.71 | $-26.32 | $-30.94 | $-21.84 | $-110.81 |
2020 | $-40.35 | $-27.54 | $-15.71 | $-20.85 | $-104.44 |
2019 | $-36.08 | $-49.05 | $-32.31 | $-52.9 | $-170.33 |
2018 | $-207.5 | $-58.75 | $-66.83 | $-47.41 | $-380.49 |
2017 | $12.44 | $-40.84 | $-19.66 | $-32.38 | $-80.44 |
2016 | $-44.91 | $-30.01 | $-50.03 | $-65.32 | $-190.27 |
2015 | $-33.28 | $-39.03 | $-41.49 | $25.8 | $-87.99 |
2014 | $17.93 | $-53.86 | $-52.94 | $3.25 | $-85.62 |
2013 | $-13.02 | $14.99 | $-6.52 | $-36.36 | $-40.91 |
2012 | $-20.49 | $-16.54 | – | – | $-81.87 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology